In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-30
DOI
10.1038/s41598-021-86658-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of an A-Site Selective Protein Disulfide Isomerase A1 Inhibitor
- (2018) Kyle S. Cole et al. BIOCHEMISTRY
- Discovery and Mechanistic Elucidation of a Class of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma
- (2018) Anahita Kyani et al. ChemMedChem
- Multifunctional molecule ERp57: From cancer to neurodegenerative diseases
- (2018) Aubryanna Hettinghouse et al. PHARMACOLOGY & THERAPEUTICS
- Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review
- (2018) Pandurangan Ashokkumar et al. World Journal of Gastrointestinal Oncology
- Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
- (2018) Kaitlin Graham et al. International Journal of Nanomedicine
- Biomarkers in colorectal cancer: Current clinical utility and future perspectives
- (2018) Marco Vacante et al. World Journal of Clinical Cases
- Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
- (2017) Jae-Kyung Won et al. HEPATOLOGY
- Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells
- (2017) Angela M. Gocher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Maximising the potential of AKT inhibitors as anti-cancer treatments
- (2017) Jessica S. Brown et al. PHARMACOLOGY & THERAPEUTICS
- PLK1, A Potential Target for Cancer Therapy
- (2017) Zhixian Liu et al. Translational Oncology
- PDI is an essential redox-sensitive activator of PERK during the unfolded protein response (UPR)
- (2017) Philip Kranz et al. Cell Death & Disease
- Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer
- (2017) Soma Samanta et al. Oncotarget
- Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma
- (2016) S. Vatolin et al. CANCER RESEARCH
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance
- (2016) Fengsheng Li et al. Oncology Letters
- Genetics, diagnosis and management of colorectal cancer (Review)
- (2015) MARINA DE ROSA et al. ONCOLOGY REPORTS
- MYC, Metabolism, and Cancer
- (2015) Z. E. Stine et al. Cancer Discovery
- Depletion of the thiol oxidoreductase ERp57 in tumor cells inhibits proliferation and increases sensitivity to ionizing radiation and chemotherapeutics
- (2015) Melanie Hussmann et al. Oncotarget
- The structural basis for cancer treatment decisions
- (2015) Ruth Nussinov et al. Oncotarget
- Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
- (2014) Erik O. Pettersen et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- ERp57/PDIA3 binds specific DNA fragments in a melanoma cell line
- (2013) Cristina Aureli et al. GENE
- Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2)
- (2013) K. Janke et al. JOURNAL OF CELL SCIENCE
- PDK1 Signaling Toward PLK1-MYC Activation Confers Oncogenic Transformation, Tumor-Initiating Cell Activation, and Resistance to mTOR-Targeted Therapy
- (2013) J. Tan et al. Cancer Discovery
- Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment
- (2012) S. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models
- (2011) K. Ellwood-Yen et al. CANCER RESEARCH
- Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer
- (2011) Chia-Jung Liao et al. CANCER SCIENCE
- Characterisation of a multimeric protein complex associated with ERp57 within the nucleus in paclitaxel-sensitive and -resistant epithelial ovarian cancer cells: The involvement of specific conformational states of β-actin
- (2010) Cicchillitti INTERNATIONAL JOURNAL OF ONCOLOGY
- Functional Relationship between Protein Disulfide Isomerase Family Members during the Oxidative Folding of Human Secretory Proteins
- (2010) Lori A. Rutkevich et al. MOLECULAR BIOLOGY OF THE CELL
- Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line
- (2009) Silvia Chichiarelli et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol
- (2009) Huanting Liu et al. BMC BIOTECHNOLOGY
- ERp57 Modulates STAT3 Signaling from the Lumen of the Endoplasmic Reticulum
- (2009) Helen Coe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ERp57 Does Not Require Interactions with Calnexin and Calreticulin to Promote Assembly of Class I Histocompatibility Molecules, and It Enhances Peptide Loading Independently of Its Redox Activity
- (2009) Yinan Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage
- (2009) N. F. Krynetskaia et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started